Apparent doubling of frequency of undescended testis in England and Wales in 1962-81.

PubWeight™: 3.54‹?› | Rank: Top 1%

🔗 View Article (PMID 6146873)

Published in Lancet on August 11, 1984

Authors

C Chilvers, M C Pike, D Forman, K Fogelman, M E Wadsworth

Articles citing this

Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11

International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect (1999) 2.70

Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe Hospital Cryptorchidism Study Group. Arch Dis Child (1992) 1.43

Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe Hospital Cryptorchidism Study Group. Br Med J (Clin Res Ed) (1986) 1.43

Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ Health Perspect (1997) 1.42

Exposure to pesticides and cryptorchidism: geographical evidence of a possible association. Environ Health Perspect (1996) 1.26

Testicular cancer mortality in England and Wales 1971-80: variations by occupation. J Epidemiol Community Health (1986) 1.19

Cryptorchidism: a registry based study in Sweden on some factors of possible aetiological importance. J Epidemiol Community Health (1989) 1.14

Auditing community screening for undescended testes. Arch Dis Child (1990) 1.10

Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect (1995) 1.10

Carcinoma in situ of the testis. Br Med J (Clin Res Ed) (1986) 1.03

The wildlife/human connection: modernizing risk decisions. Environ Health Perspect (1994) 1.00

Screening for undescended testes. Arch Dis Child (1991) 0.98

Effect of neonatal exposure to estrogenic compounds on development of the excurrent ducts of the rat testis through puberty to adulthood. Environ Health Perspect (1999) 0.93

Cryptorchidism in Scotland. Br Med J (Clin Res Ed) (1987) 0.93

Increase in hospital admissions for torsion of testis. J Epidemiol Community Health (1986) 0.92

Prevalence of acquired undescended testis in 6-year, 9-year and 13-year-old Dutch schoolboys. Arch Dis Child (2006) 0.90

Orchidopexy: theory and practice. Br Med J (Clin Res Ed) (1985) 0.89

Temporal trends in orchidopexy, Great Britain, 1992-1998. Environ Health Perspect (2003) 0.88

The timing of surgery for undescended testis - a retrospective multicenter analysis. Dtsch Arztebl Int (2014) 0.85

An assay for the detection of xenoestrogens based on a promoter containing overlapping EREs. Environ Health Perspect (1999) 0.83

Similar causes of various reproductive disorders in early life. Asian J Androl (2013) 0.82

The tammar wallaby (Macropus eugenii) and the Sprague-Dawley rat: comparative anatomy and physiology of inguinoscrotal testicular descent. J Anat (1993) 0.81

Torsion of the testis: a new risk factor for testicular cancer. Br J Cancer (1987) 0.80

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89. Br J Cancer (1995) 0.79

[Multimodal therapy of cryptorchism]. Urologe A (2006) 0.78

Prepubertal unilateral spermatic vessel ligation decreases haploid cell population of ipsilateral testis postpubertally in rats. Pediatr Surg Int (2005) 0.77

Paternal exposures to environmental chemicals and time-to-pregnancy: overview of results from the LIFE study. Andrology (2016) 0.75

Boys with late descending testes: the source of patients with "retractile" testes undergoing orchidopexy? Br Med J (Clin Res Ed) (1986) 0.75

Undescended testes: early versus late maldescent. Pediatr Surg Int (1997) 0.75

Articles by these authors

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55

Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03

A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17

Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ (1989) 12.20

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet (2010) 11.06

Coping with stress during childhood and adolescence: problems, progress, and potential in theory and research. Psychol Bull (2001) 6.32

Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1977) 5.87

Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07

Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer. Br J Gen Pract (1995) 5.03

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst (2000) 4.93

The effect of deprivation on variations in general practitioners' referral rates: a cross sectional study of computerised data on new medical and surgical outpatient referrals in Nottinghamshire. BMJ (1997) 4.85

Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46

Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38

Responses to stress in adolescence: measurement of coping and involuntary stress responses. J Consult Clin Psychol (2000) 3.90

Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63

Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg (1986) 3.54

Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42

Blood pressure in a national birth cohort at the age of 36 related to social and familial factors, smoking, and body mass. Br Med J (Clin Res Ed) (1985) 3.39

Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population based study. BMJ (2001) 3.38

Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38

Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst (1999) 3.35

Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30

Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30

Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07

Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03

Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99

Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol (1988) 2.91

Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89

A method of analysis of a certain class of experiments in carcinogenesis. Biometrics (1966) 2.86

Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ (1994) 2.83

Onset of obesity in a 36 year birth cohort study. Br Med J (Clin Res Ed) (1986) 2.83

Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer (2009) 2.79

Academic and non-academic predictors of success on the Nottingham undergraduate medical course 1970-1995. Med Educ (2001) 2.79

Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ (1997) 2.71

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59

Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58

Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54

Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50

Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45

The long-term prognosis of severe infantile malnutrition. Lancet (1967) 2.44

Burkitt's tumour in the West Nile District Uganda, 1961-5. Br Med J (1967) 2.43

Toward the primary prevention of cancer. Science (1991) 2.41

Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 2.40

Sexual behaviour of young and middle aged men in England and Wales. BMJ (1989) 2.37

Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34

On the estimation of relative risk from vital statistical data. J Epidemiol Community Health (1979) 2.34

An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics (1978) 2.32

Time course of response to prednisolone in chronic airflow obstruction. Thorax (1981) 2.28

Does pregnancy protect against ovarian cancer? Lancet (1978) 2.28

Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26

Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst (2000) 2.24

Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22

"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18

Nitrates, nitrites and gastric cancer in Great Britain. Nature (1985) 2.15

An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15

Physical health status at 36 years in a British national birth cohort. Soc Sci Med (1993) 2.15

Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer (2010) 2.13

Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol (1976) 2.11

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08

Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07

Disease clustering: a generalization of Knox's approach to the detection of space-time interactions. Biometrics (1968) 2.06

Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05

Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 2.05

The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04

Adjustment of children and adolescents to parental cancer. Parents' and children's perspectives. Cancer (1996) 2.03

A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet (1973) 2.02

Chemoattractant receptors on phagocytic cells. Annu Rev Immunol (1984) 2.01

Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1980) 1.99

Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer (2008) 1.97

Helicobacter gastroduodenitis: a serious infectious disease. BMJ (1997) 1.90

The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg (1986) 1.90

Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci U S A (1978) 1.89

Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring. J Epidemiol Community Health (1992) 1.89

Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst (1994) 1.87

Slow mortality rate accelerations during aging in some animals approximate that of humans. Science (1990) 1.86

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85

Long survivals in acute leukaemia. Lancet (1973) 1.85

Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res (1993) 1.82

Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81

Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol (1977) 1.81

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer (1991) 1.81

Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80

The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer (2007) 1.79

An inhibitor of macrophage chemotaxis produced by neoplasms. Science (1976) 1.79

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77